Given its integral role in liver function, prior studies have linked the downregulation of SIRT1 to the onset and progression of non-alcoholic fatty liver disease (NAFLD) (Colak et al., 2011; Martins, 2017c). Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.